Cline Scientific AB (publ), a life science company, develops cancer diagnostics and stem cell therapies in Sweden. The company’s clinical-stage projects include StemCART, a stem cell therapy for joint repair; and CellRACE, a cancer diagnostic to predict metastasis. It also develops nanotechnology based products for work within Life Sciences. The company has collaboration with Sahlgrenska that develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells that can self-heal cartilage, as well as with researchers and Liv Diagnostics for cancer research. Cline Scientific AB (publ) was incorporated in 2011 and is based in Mölndal, Sweden.
Metrics to compare | CLINEb | Peers Peers - average of corresponding metrics from companies closely matching CLINEb: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLINEbPeersSector |
---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | 0.0x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 0.0x | |
Price / LTM Sales | 0.0x | 0.0x | 0.0x | |
Upside (Analyst Target) | 0.0% | 0.0% | 0.0% | |
Fair Value Upside | Unlock | 0.0% | 0.0% | Unlock |